About Glycotope
Glycotope GmbH is a biotechnology company that uniquely develops tumor-specific monoclonal antibodies. We are dedicated to improving the lives of cancer patients by enabling treatment options that go beyond the current standard of care. Together with our partners in the pharmaceutical industry and academic research, we strive to combine our antibodies with complementary technologies to realize their full potential.
- Focus : Manufacturer
- Employees: 51-200
- Industry : Biotechnology
Product portfolio of Glycotope
News about Glycotope
Here you will find Glycotope GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
